A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.

FDA reccommends checking the shelf life of COVID anitigen test close to expiring due to some test with different dates from ...

No FDA-approved rapid tests exist that specifically test for H5N1, and the first near-point-of-care test for mpox was ...

DelveInsight's D-Dimer Testing Market Insights report provides the current and forecast market analysis, individual leading D ...

The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...

The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...

and more rapid recoveries. The findings were reported in Science Translational Medicine. The researchers wanted to measure ...

The global rapid hepatitis testing market is set to make significant strides, with an estimated valuation of USD 3.2 billion ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Thoughtworks' 2024 Technology Radar highlights rapid AI growth in software engineering, urging developers to adopt best ...

A special message to Votebeat readers from editor-in-chief Chad Lorenz: As early voting wraps up, America’s election system ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...